MedPath

Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction

Completed
Conditions
Oncologic Disorders
Pancreatic Cancer
Endoscopy
Therapy Related Neoplasms
Registration Number
NCT04420039
Lead Sponsor
Hospital Universitari de Bellvitge
Brief Summary

There are doubts concerning the possible benefits derived from the insertion of double-pigtail plastic stents (DPS) within the lumen-apposing metal stents (LAMS) in the EUS-guided transmural biliary drainage (BD). The aims was to evaluate the safety of LAMS with and without a coaxial DPS in EUS-BD for the palliative management in malignant biliary obstruction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Consecutive unresectable/inoperable biliopancreatic cases with distal biliary obstruction who underwent EUS-BD after failed ERCP cannulation or inaccessible papilla
Exclusion Criteria
  • Borderline cancer cases
  • Others type of biliary stents
  • Severe coagulopathy or thrombocytopenia.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Potential benefits4 weeks

to respond if a coaxial DPS within a biliary LAMS really has a potential benefit in the EUS-BD (less number of adverse events: cholangitis, bleeding, sump syndrome, cholestasis secondary to stent biliary obstruction)

Secondary Outcome Measures
NameTimeMethod
Technical success24 hours

Technical success was defined as a successful stent placement between the extrahepatic bile duct and duodenal lumen in a single step approach and determined by endoscopy and fluoroscopy

Clinical success4 weeks

Clinical success was defined as a reduction in bilirubin by 50% at 2-weeks after stent placement, meaning that the biliary stent was functional.

Procedure time2 hours

Procedure time was defined from the insertion of the endoscope to its removal.

Biliary reintervention6 months

Biliary reintervention: the need to perform additional interventions to achieve biliary drainage.

Trial Locations

Locations (3)

Hospital Universitari Mútua de Terrassa

🇪🇸

Terrassa, Barcelona, Catalonia, Spain

Hospital Universitari de Bellvitge

🇪🇸

L'Hospitalet de Llobregat, Barcelona, Spain

Hospital de Sant Pau i de la Santa Creu

🇪🇸

Barcelona, Catalonia, Spain

Hospital Universitari Mútua de Terrassa
🇪🇸Terrassa, Barcelona, Catalonia, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.